![](/img/cover-not-exists.png)
Results from a Phase I Clinical Study of the Novel Ii-Key/HER-2/neu(776-790) Hybrid Peptide Vaccine in Patients with Prostate Cancer
Perez, S. A., Kallinteris, N. L., Bisias, S., Tzonis, P. K., Georgakopoulou, K., Varla-Leftherioti, M., Papamichail, M., Thanos, A., von Hofe, E., Baxevanis, C. N.Volume:
16
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-10-0085
Date:
July, 2010
File:
PDF, 1.14 MB
english, 2010